Delivery Order SPE2DB22D6029-SPE2DB24FU1KS

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,919.60 Delivery Order placed by the Defense Logistics Agency (DLA). The award is for the provision of a pharmaceutical product, specifically ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, with a period of performance through July 2, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,069.45 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA), a defense agency. The award is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" and has a completion date of June 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $4,654.24 firm fixed-price delivery order contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order with a Firm Fixed Price valued at $1,053.76. The award is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" with an ultimate completion date of May 21, 2024. The contract is under the Medical Supply Chain program of the Defense Logistics Agency (DLA), which serves the U.S. Department of Defense. This award does not have a set-aside designation,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,773.03 Firm Fixed Price Delivery Order contract is for ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025 and was awarded on April 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $4,451.40 for the supply of a pharmaceutical product, ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract is issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $3,687.28 firm-fixed-price delivery order contract to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is to provide the product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" and has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,698.10 for the supply of the pharmaceutical product "ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML". The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), which is the primary logistics provider for the U.S. Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,205.89, to provide the pharmaceutical product "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML" to support military healthcare programs. The contract has an ultimate completion date of February 7, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA). The $1,380.66 firm fixed price delivery order is for the supply of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML". Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB24FU1KS
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $2,107.52, is for the delivery of 4565015384 ! ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The award is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense.

Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order is not associated with a set-aside designation. The contract has an ultimate completion date of June 28, 2024.

Generated 9/26/24, 9:42 AM